Ketoacid Analogues Intradialytic Effect on Inflammation
NCT ID: NCT06392516
Last Updated: 2024-04-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
86 participants
INTERVENTIONAL
2024-04-29
2024-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Application of Citrate Dialysate in Chronic Haemodialysis
NCT01532297
Immuno-nutrition Supplementation in Haemodialysis
NCT05700851
Comparison Between HA330 Hemoperfusion Filter Hemodialysis and Conventional High-Flux Hemodialysis Filter
NCT05941624
Multiple-dose Pharmacokinetics of Ceftaroline During Continuous and Intermittent Renal Replacement Therapy in Patients Requiring Renal Replacement Therapy
NCT02007122
Dexmedetomidine Pharmacokinetics During Continuous Renal Replacement Therapy (CRRT)
NCT01314209
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* interleukin 6
* malnutrition inflammation score
* neutrophil lymphocyte ratio
* monocyte lymphocyte ratio
* thrombocyte lymphocyte ratio
the duration of intervention is 12 weeks
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
control
patient who undergo hemodialysis two times a week
No interventions assigned to this group
intervention
will be given parenteral ketoacid analogues intradialytics two times a week
Ketoacid
250 ml ketoacid two hours before the hemodialysis session ended
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ketoacid
250 ml ketoacid two hours before the hemodialysis session ended
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* acute conditions
* HIV patient
* acute infection
* stroke and immobilized patient
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
RSUP Fatmawati
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Anggraini Permata Sari
Internal Medicine Staff, Fellow of Nephrology Division
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
RSUP Fatmawati
Jakarta, Jakarta Selatan, Indonesia
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RSF_IPDGH_01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.